Lawson Elizabeth A
Neuroendocrine Unit, Massachusetts General Hospital, 55 Fruit Street, Bulfinch 457 D, Boston, Massachusetts 02114, USA.
Nat Rev Endocrinol. 2017 Dec;13(12):700-709. doi: 10.1038/nrendo.2017.115. Epub 2017 Sep 29.
Oxytocin, a hypothalamic hormone that is secreted directly into the brain and enters the peripheral circulation through the posterior pituitary gland, regulates a range of physiologic processes, including eating behaviour and metabolism. In rodents and nonhuman primates, chronic oxytocin administration leads to sustained weight reduction by reducing food intake, increasing energy expenditure and inducing lipolysis. Oxytocin might improve glucose homeostasis, independently of its effects on weight. Clinical studies are beginning to translate these important preclinical findings to humans. This Review describes key data linking oxytocin to eating behaviour and metabolism in humans. For example, a single intranasal dose of oxytocin can reduce caloric intake, increase fat oxidation and improve insulin sensitivity in men. Furthermore, a pilot study of 8 weeks of oxytocin treatment in adults with obesity or overweight led to substantial weight loss. Together, these data support further investigation of interventions that target pathways involving oxytocin as potential therapeutics in metabolic disorders, including obesity and diabetes mellitus. Therapeutic considerations and areas for further research are also discussed.
催产素是一种下丘脑激素,直接分泌到大脑中,并通过垂体后叶进入外周循环,调节一系列生理过程,包括饮食行为和新陈代谢。在啮齿动物和非人类灵长类动物中,长期给予催产素可通过减少食物摄入量、增加能量消耗和诱导脂肪分解来持续减轻体重。催产素可能改善葡萄糖稳态,而与它对体重的影响无关。临床研究开始将这些重要的临床前研究结果应用于人类。本综述描述了将催产素与人类饮食行为和新陈代谢联系起来的关键数据。例如,单次鼻内给予催产素可减少男性的热量摄入、增加脂肪氧化并改善胰岛素敏感性。此外,一项针对肥胖或超重成年人进行的为期8周的催产素治疗的初步研究导致了显著的体重减轻。这些数据共同支持进一步研究针对涉及催产素途径的干预措施,将其作为肥胖和糖尿病等代谢紊乱的潜在治疗方法。还讨论了治疗方面的考虑因素和进一步研究的领域。